LigaChem Biosciences Inc. (KOSDAQ:141080)
South Korea · Delayed Price · Currency is KRW 95,400
+7,900 (9.03%)
Aug 3, 2026, 3:30 PM KST
LigaChem Biosciences Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 125,866 | 141,553 | 125,898 | 34,146 | 33,412 | 32,157 |
Revenue Growth | -14.04% | 12.44% | 268.71% | 2.20% | 3.90% | -44.07% |
Gross Profit Gross Profit Growth | 111,943 | 125,996 | 109,948 | 17,797 | 17,849 | 17,698 |
Operating Income Operating Income Growth | -155,281 | -106,486 | -20,913 | -80,822 | -50,375 | -27,707 |
Net Income Net Income Growth | -138,082 | -74,278 | 7,800 | -73,704 | -45,092 | -23,391 |
Earnings Per Share EPS Growth | -3791.57 | -2042.00 | 224.00 | -2595.00 | -1609.47 | -970.00 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceutical Business Pharmaceutical Business Growth | 18,284 | 20,392 | 20,538 | 21,342 | 20,331 | 19,226 |
New Drug Research and Development New Drug Research and Development Growth | 107,582 | 121,161 | 105,360 | 12,804 | 13,081 | 12,931 |
Total Total Growth | 125,866 | 141,553 | 125,898 | 34,146 | 33,412 | 32,157 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 428,339 | 474,548 | 493,947 | 99,925 | 169,946 | 180,814 |
Total Debt Total Debt Growth | 2,603 | 2,749 | 819.87 | 12,644 | 12,249 | 12,269 |
Net Cash (Debt) Net Cash Growth | 425,737 | 471,798 | 493,128 | 87,281 | 157,697 | 168,545 |
Net Cash Growth | -8.63% | -4.32% | 464.99% | -44.65% | -6.44% | 82.06% |
Net Cash Per Share Net Cash Per Share Growth | 11689.76 | 12968.55 | 14189.22 | 3072.85 | 5628.72 | 6986.35 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -140,516 | -124,533 | 78,476 | -62,236 | -7,136 | -42,049 |
Capital Expenditures CapEx Growth | -3,112 | -3,050 | -2,628 | -1,319 | -4,164 | -18,309 |
Free Cash Flow Free Cash Flow Growth | -143,628 | -127,582 | 75,849 | -63,555 | -11,300 | -60,358 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 88.94% | 89.01% | 87.33% | 52.12% | 53.42% | 55.04% |
Operating Margin | -123.37% | -75.23% | -16.61% | -236.70% | -150.77% | -86.16% |
Pretax Margin | -122.86% | -66.33% | 7.25% | -221.83% | -142.83% | -63.82% |
Profit Margin | -109.71% | -52.47% | 6.20% | -215.85% | -134.96% | -72.74% |
FCF Margin | -114.11% | -90.13% | 60.25% | -186.13% | -33.82% | -187.70% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 509.64 | - | - | - |
Forward PE | - | 129.34 | 52.06 | 44.50 | 44.50 | 44.50 |
P/FCF Ratio | - | - | 52.41 | - | - | - |
PS Ratio | 27.93 | 44.67 | 31.58 | 53.52 | 32.71 | 42.05 |